Regulatory effects of IL-18 on cytokine profiles and development of myocarditis during Trypanosoma cruzi infection

Microbes and Infection

Volumn 16, Issue 6, 2014, Pages 481-490

  Esper, Lísia ^a   Utsch, Lara ^a   Soriani, Frederico M ^a   Brant, Fátima ^a   Esteves Arantes, Rosa Maria ^a   Campos, Camila F ^a   Pinho, Vanessa ^a   Souza, Danielle G ^a   Teixeira, Mauro Martins ^a   Tanowitz, Herbert Bernard ^b   Vieira, Leda Quercia ^a,c   Machado, Fabiana Simão ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Cytokine; IL 18; Myocarditis; Trypanosoma cruzi

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEART DISEASE; HISTOPATHOLOGY; HOST PARASITE INTERACTION; IMMUNE RESPONSE; KNOCKOUT MOUSE; MOUSE; MYOCARDITIS; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; STRAIN DIFFERENCE; TRYPANOSOMA CRUZI; ANIMAL; BLOOD; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; COMPLICATION; CYTOLOGY; GENETICS; HEART MUSCLE; IMMUNOLOGY; MALE; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; SPLEEN;

MUS; TRYPANOSOMA CRUZI;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHAGAS DISEASE; HOST-PARASITE INTERACTIONS; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDITIS; MYOCARDIUM; SPLEEN; TRYPANOSOMA CRUZI;

EID: 84902785175     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.03.007     Document Type: Article

References (35)

1. Rassi A., Rassi A., Marin-Neto J.A. Chagas disease. Lancet 2010, 375:1388-1402.
2. Machado F.S., Dutra W.O., Esper L., Gollob K.J., Teixeira M.M., Factor S.M., et al. Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Semin Immunopathol 2012, 34:753-770.
3. Rodrigues A.A., Saosa J.S., da Silva G.K., Martins F.A., da Silva A.A., Souza Neto C.P., et al. IFN-gamma plays a unique role in protection against low virulent Trypanosoma cruzi strain. PLoS Negl Trop Dis 2012, 6:e1598.
4. Silva J.S., Morrissey P.J., Grabstein K.H., Mohler K.M., Anderson D., Reed S.G. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 1992, 175:169-174.
5. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
6. Machado F.S., Tyler K.M., Brant F., Esper L., Teixeira M.M., Tanowitz H.B. Pathogenesis of Chagas disease: time to move on. Front Biosci (Elite Ed) 2012, 4:1743-1758.
7. Antunez M.I., Cardoni R.L. Early IFN-γ production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections. Immunol Lett 2001, 79:189-196.
8. Nakamura K., Okamura H., Wada M., Nagata K., Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 1989, 57:590-595.
9. Puren A.J., Razeghi P., Fantuzzi G., Dinarello C.A. Interleukin-18 enhances lipopolysaccharide-induced interferon-gamma production in human whole blood cultures. J Infect Dis 1998, 178:1830-1834.
10. Mailliard R.B., Alber S.M., Shen H., Watkins S.C., Kirkwood J.M., Herberman R.B., et al. IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med 2005, 202:941-953.
11. Kobayashi K., Kai M., Gidoh M., Nakata N., Endoh M., Singh R.P., et al. The possible role of interleukin (IL)-12 and interferon-gamma-inducing factor/IL-18 in protection against experimental Mycobacterium leprae infection in mice. Clin Immunol Immunopathol 1998, 88:226-231.
12. Kawakami K., Qureshi M.H., Zhang T., Okamura H., Kurimoto M., Saito A. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J Immunol 1997, 159:5528-5534.
13. Hein J., Sing A., Di Genaro M.S., Autenrieth I.B. Interleukin-12 and interleukin-18 are indispensable for protective immunity against enteropathogenic Yersinia. Microb Pathog 2001, 31:195-199.
14. Kanda T., Tanaka T., Sekiguchi K., Seta Y., Kurimoto M., Wilson McManus J.E., et al. Effect of interleukin-18 on viral myocarditis: enhancement of interferon-gamma and natural killer cell activity. J Mol Cell Cardiol 2000, 32:2163-2171.
15. Murray H.W., Tsai C.W., Liu J., Ma X. Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18. Infect Immun 2006, 74:4370-4374.
16. Fairweather D., Yusung S., Frisancho S., Barrett M., Gatewood S., Steele R., et al. IL-12 receptor beta 1 and toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 2003, 170:4731-4737.
17. Rodriguez-Galan M.C., Reynolds D., Correa S.G., Iribarren P., Watanabe M., Young H.A. Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity. J Immunol 2009, 183:740-748.
18. Graefe S.E., Jacobs T., Gaworski I., Klauenberg U., Steeg C., Fleischer B. Interleukin-12 but not interleukin-18 is required for immunity to Trypanosoma cruzi in mice. Microbes Infect 2003, 5:833-839.
19. Buschenfelde C.M.Z., Cramer S., Trumpfheller C., Fleischer B., Frosch S. Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression invivo: correlation with interferon-gamma (IFN-g) production. Clin Exp Immunol 1997, 110:378-385.
20. Esper L., Roman-Campos D., Lara A., Brant F., Castro L.L., Barroso A., et al. Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. Am J Pathol 2012, 181:130-140.
21. Macedo A.M., Pena S.D. Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas disease. Parasitol Today 1998, 14:119-124.
22. Devera R., Illarramendi X., Montoya-Araujo R., Pirmez C., Fernandes O., Coura J.R. Rev Soc Bras Med Trop 2002, 35:323-330.
23. Machado F.S., Martins G.A., Aliberti J.C., Mestriner F.L., Cunha F.Q., Silva J.S. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 2000, 102:3003-3008.
24. Machado F.S., Koyama N.S., Carregaro V., Ferreira B.R., Milanezi C.M., Teixeira M.M., et al. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J Infect Dis 2005, 191:627-636.
25. Ferreira L.R., Abrantes E.F., Rodrigues C.V., Caetano B., Cerqueira G.C., Salim A.C., et al. Identification and characterization of a novel mouse gene encoding a Ras-associated guanine nucleotide exchange factor: expression in macrophages and myocarditis elicited by Trypanosoma cruzi parasites. J Leukoc Biol 2002, 72:1215-1227.
26. Netea M.G., Kullberg B.J., Verschueren I., Van Der Meer J.W. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur J Immunol 2000, 30:3057-3060.
27. Monteforte G.M., Takeda K., Rodriguez-Sosa M., Akira S., David J.R., Satoskar A.R. Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection. J Immunol 2000, 164:5890-5893.
28. Pinge-Filho P., Takodoro C.E., Abrahamsohn I.d.A. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell Immunol 1999, 193:90-98.
29. Betz M., Fox B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991, 146:108-113.
30. Mohan K., Cordeiro E., Vaci M., McMaster C., Issekutz T.B. CXCR3 is required for migration to dermal inflammation by normal and invivo activated T cells: differential requirements by CD4 and CD8 memory subsets. Eur J Immunol 2005, 35:1702-1711.
31. Paiva C.N., Figueiredo R.T., Kroll-Palhares K., Silva A.A., Silverio J.C., Gibaldi D., et al. CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection. J Leukoc Biol 2009, 86:1239-1246.
32. Cavaillon J.M. Cytokines and macrophages. Biomed Pharmacother 1994, 48:445-453.
33. Dinarello C.A. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002, 20:S1-S13.
34. Dao T., Ohashi K., Kayano T., Kurimoto M., Okamura H. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol 1996, 173:230-235.
35. Dao T., Mehal W.Z., Crispe I.N. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 1998, 161:2217-2222.